Hiroki Chiba
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hiroki Chiba has a total of 70 co-authors. Here are the top co-authors by number of shared publications:
- Takeya Kitta
Department of Renal and Urologic Surgery Asahikawa Medical University Asahikawa Japan
5 shared publications Madoka Higuchi
Department of Renal and Genitourinary Surgery Hokkaido University Graduate School of Medicine Sapporo Japan
3 shared publications- Mifuka Ouchi
Department of Renal and Genitourinary Surgery, Graduate School of Medicine Hokkaido University Sapporo Hokkaido Japan
3 shared publications - Mio Togo
Department of Renal and Genitourinary Surgery, Graduate School of Medical Science Hokkaido University Sapporo Japan
3 shared publications - Madoka Higuchi
Department of Urology National Defense Medical College Saitama Japan
2 shared publications - Mayuko Tsukiyama
Department of Renal and Genitourinary Surgery, Hokkaido University, Graduate School of Medicine, Sapporo, Japan
2 shared publications
Latest Publications
- 2 September 2026
- Published by Wiley in Pathology International
- Vol. 76 (9)
Urothelial Carcinoma With Loss of SMARCA4 Expression With the Site of Origin Identified by Detailed Autopsy Investigation
- 2 September 2026
- Published by Wiley in Pathology International
- Vol. 76 (9)
Urothelial Carcinoma With Loss of SMARCA4 Expression With the Site of Origin Identified by Detailed Autopsy Investigation
- 4 May 2026
- Published by Wiley in International Journal of Urology
- Vol. 33 (5) , e70482
A Novel Prediction Model for Monorchidism in Boys With Unilateral Nonpalpable Testes: Diagnostic Utility of Preoperative Ultrasonography
Introduction: In boys with non‐palpable testis (NPT), the affected side may present as a viable testis (VT) or a nonviable testis (NVT), the latter representing true monorchidism. This study evaluated the utility of ultrasonography (US) for predicting monorchidism and testicular location in unilateral NPT. Methods: We retrospectively reviewed boys with unilateral NPT who underwent preoperative US between 2009 and 2025. Testicular volumes were converted to age‐adjusted standard deviation (SD) scores. A rule‐based model classified NVT when the affected testis was visualized with an SD score ≤ cutoff A and the unaffected testis had an SD score ≥ cutoff B. If the affected testis was not visualized, an SD score ≥ cutoff C for the unaffected testis indicated NVT; remaining cases were classified as VT. Predictions were compared with intraoperative findings. Receiver operating characteristic analysis determined optimal cutoffs. Internal validation using repeated stratified five‐fold cross‐validation and bootstrap resampling assessed model performance and threshold stability. US‐based localization was also compared with surgical findings. Results: Sixty‐nine boys were included; surgery identified 51 NVT and 18 VT. Optimal cutoffs were A = −2.60, B = +0.45, and C = +0.60. The model achieved an AUC of 96.1%, with 100% sensitivity, 92.2% specificity, 81.8% positive predictive value, and 100% negative predictive value. Internal validation showed median AUCs of 90.0% and 89.4%, with stable thresholds. Localization accuracy was 66.6%. Conclusion: A rulebased US model may predict monorchidism in unilateral NPT with a very low risk of misclassifying VT as NVT, despite its limited ability to determine testicular location.
- 4 May 2026
- Published by Wiley in International Journal of Urology
- Vol. 33 (5) , e70482
A Novel Prediction Model for Monorchidism in Boys With Unilateral Nonpalpable Testes: Diagnostic Utility of Preoperative Ultrasonography
Introduction: In boys with non‐palpable testis (NPT), the affected side may present as a viable testis (VT) or a nonviable testis (NVT), the latter representing true monorchidism. This study evaluated the utility of ultrasonography (US) for predicting monorchidism and testicular location in unilateral NPT. Methods: We retrospectively reviewed boys with unilateral NPT who underwent preoperative US between 2009 and 2025. Testicular volumes were converted to age‐adjusted standard deviation (SD) scores. A rule‐based model classified NVT when the affected testis was visualized with an SD score ≤ cutoff A and the unaffected testis had an SD score ≥ cutoff B. If the affected testis was not visualized, an SD score ≥ cutoff C for the unaffected testis indicated NVT; remaining cases were classified as VT. Predictions were compared with intraoperative findings. Receiver operating characteristic analysis determined optimal cutoffs. Internal validation using repeated stratified five‐fold cross‐validation and bootstrap resampling assessed model performance and threshold stability. US‐based localization was also compared with surgical findings. Results: Sixty‐nine boys were included; surgery identified 51 NVT and 18 VT. Optimal cutoffs were A = −2.60, B = +0.45, and C = +0.60. The model achieved an AUC of 96.1%, with 100% sensitivity, 92.2% specificity, 81.8% positive predictive value, and 100% negative predictive value. Internal validation showed median AUCs of 90.0% and 89.4%, with stable thresholds. Localization accuracy was 66.6%. Conclusion: A rulebased US model may predict monorchidism in unilateral NPT with a very low risk of misclassifying VT as NVT, despite its limited ability to determine testicular location.
- Open Access
- 11 March 2026
- Published by Wiley in LUTS: Lower Urinary Tract Symptoms
- Vol. 18 (2) , e70058
A Survey on Real‐World Transurethral Surgery Procedures for Bladder Pain Syndrome and Interstitial Cystitis
Objectives: To investigate real‐world practices in transurethral surgeries for bladder pain syndrome (BPS) and interstitial cystitis (IC) in Japan, with a focus on procedural characteristics of hydrodistension (HD) and transurethral elimination of Hunner lesions (TUEH). Methods: An internet‐based questionnaire was sent to all members of the Society of Interstitial Cystitis of Japan in November 2024. The survey inquired about institutional characteristics, the number of procedures performed in the previous 12 months, and detailed surgical techniques. BPS was defined by the absence of Hunner lesions, and IC by their presence. Responses were analyzed to describe procedural patterns and compare practices between HD and TUEH. Results: Of 205 eligible members, 86 responded (response rate: 42%). Among them, 52 had performed HD for BPS and 67 had performed TUEH for IC within the study period. Most surgeons distended the bladder to a preset pressure of ≤ 80 cm H 2 O for 3–10 min and repeated the procedure at least twice during HD. At TUEH, coagulation was preferred over resection to eliminate Hunner lesions. HD was frequently co‐performed, though the sequence of elimination and HD varied. Compared to HD, TUEH more often relied on abdominal palpation rather than fixed pressure, used shorter distension time, and involved longer catheter placement. Conclusions: This nationwide survey highlights contemporary surgical practices for BPS and IC in Japan. These findings may help clinicians evaluate and refine their own approaches to transurethral interventions for these complex conditions.
- 11 March 2026
- Published by Wiley in LUTS: Lower Urinary Tract Symptoms
- Vol. 18 (2) , e70058
Open AccessA Survey on Real‐World Transurethral Surgery Procedures for Bladder Pain Syndrome and Interstitial Cystitis
Objectives: To investigate real‐world practices in transurethral surgeries for bladder pain syndrome (BPS) and interstitial cystitis (IC) in Japan, with a focus on procedural characteristics of hydrodistension (HD) and transurethral elimination of Hunner lesions (TUEH). Methods: An internet‐based questionnaire was sent to all members of the Society of Interstitial Cystitis of Japan in November 2024. The survey inquired about institutional characteristics, the number of procedures performed in the previous 12 months, and detailed surgical techniques. BPS was defined by the absence of Hunner lesions, and IC by their presence. Responses were analyzed to describe procedural patterns and compare practices between HD and TUEH. Results: Of 205 eligible members, 86 responded (response rate: 42%). Among them, 52 had performed HD for BPS and 67 had performed TUEH for IC within the study period. Most surgeons distended the bladder to a preset pressure of ≤ 80 cm H 2 O for 3–10 min and repeated the procedure at least twice during HD. At TUEH, coagulation was preferred over resection to eliminate Hunner lesions. HD was frequently co‐performed, though the sequence of elimination and HD varied. Compared to HD, TUEH more often relied on abdominal palpation rather than fixed pressure, used shorter distension time, and involved longer catheter placement. Conclusions: This nationwide survey highlights contemporary surgical practices for BPS and IC in Japan. These findings may help clinicians evaluate and refine their own approaches to transurethral interventions for these complex conditions.
- 5 November 2024
- Published by Wiley in International Journal of Urology
- Vol. 32 (1) , 118-120
Successful kidney transplantation improves atrophic bladder capacity and function within 3 months in long‐term dialysis patients
- 5 November 2024
- Published by Wiley in International Journal of Urology
- Vol. 32 (1) , 118-120
Successful kidney transplantation improves atrophic bladder capacity and function within 3 months in long‐term dialysis patients
- 18 September 2023
- Published by Wiley in LUTS: Lower Urinary Tract Symptoms
- Vol. 15 (6) , 265-270
Effects of a new selective β3‐adrenoceptor agonist, vibegron, on bladder and urethral function in a rat model of Parkinson's disease
Objectives: Parkinson's disease caused by the loss of dopaminergic neurons induces not only motor dysfunction but also lower urinary tract dysfunction. Patients with Parkinson's disease have recently been reported to experience both urge urinary incontinence (overactive bladder) and stress urinary incontinence, the latter of which occurs when the pressure of the bladder exceeds that of the urethra. Vibegron is a highly selective novel β3‐adrenoceptor agonist approved for the treatment of overactive bladder. However, how β3‐adrenoceptor agonists affect urethral function remains unclear. In a clinical report, the urethral function of patients with Parkinson's disease was shown to be degraded. The present study aimed to investigate the effects of vibegron on lower urinary tract activity in a rat model of Parkinson's disease.Methods: In a rat model of Parkinson's disease induced by unilateral 6‐hydroxydopamine injection into the substantia nigra pars compacta, we examined the effects of vibegron on bladder and urethral activity.Results: Cystometric analysis revealed that, compared with vehicle injection, intravenous injection of 3 mg/kg vibegron significantly increased the inter‐contraction interval (p < .05) and reduced voiding pressure (p < .01). However, no significant effects on urethral function were observed.Conclusions: The results of the present study provide corroborating evidence that bladder dysfunction is suppressed by the administration of vibegron in Parkinson's disease model rats, confirming that vibegron is effective for treating overactive bladder without further worsening urethral function. These findings may contribute to a better understanding of the mechanisms of β3‐adrenoceptor agonists.
- 18 September 2023
- Published by Wiley in LUTS: Lower Urinary Tract Symptoms
- Vol. 15 (6) , 265-270
Effects of a new selective β3‐adrenoceptor agonist, vibegron, on bladder and urethral function in a rat model of Parkinson's disease
Objectives: Parkinson's disease caused by the loss of dopaminergic neurons induces not only motor dysfunction but also lower urinary tract dysfunction. Patients with Parkinson's disease have recently been reported to experience both urge urinary incontinence (overactive bladder) and stress urinary incontinence, the latter of which occurs when the pressure of the bladder exceeds that of the urethra. Vibegron is a highly selective novel β3‐adrenoceptor agonist approved for the treatment of overactive bladder. However, how β3‐adrenoceptor agonists affect urethral function remains unclear. In a clinical report, the urethral function of patients with Parkinson's disease was shown to be degraded. The present study aimed to investigate the effects of vibegron on lower urinary tract activity in a rat model of Parkinson's disease.Methods: In a rat model of Parkinson's disease induced by unilateral 6‐hydroxydopamine injection into the substantia nigra pars compacta, we examined the effects of vibegron on bladder and urethral activity.Results: Cystometric analysis revealed that, compared with vehicle injection, intravenous injection of 3 mg/kg vibegron significantly increased the inter‐contraction interval (p < .05) and reduced voiding pressure (p < .01). However, no significant effects on urethral function were observed.Conclusions: The results of the present study provide corroborating evidence that bladder dysfunction is suppressed by the administration of vibegron in Parkinson's disease model rats, confirming that vibegron is effective for treating overactive bladder without further worsening urethral function. These findings may contribute to a better understanding of the mechanisms of β3‐adrenoceptor agonists.
- Open Access
- 1 May 2023
- Published by AVES YAYINCILIK A.Ş. in Urology Research and Practice
- Vol. 49 (3) , 211-215
Episodes of Febrile Urinary Tract Infections Occur More Often in the Winter in Patients with Spina Bifida
Objective: Febrile urinary tract infections, which commonly occur in spina bifida patients, can cause renal dysfunction. To help prevent febrile urinary tract infection occurrence, a better understanding of any seasonal tendencies would be beneficial. Materials and Methods: Study points evaluated included: (i) with or without febrile urinary tract infections, (ii) type of urinary management in patients with febrile urinary tract infections, (iii) number of febrile urinary tract infection occurrences, and (iv) season associated with episode. Febrile urinary tract infection was defined by medical records specifically ascribing the term and clinical presentations consistent with the diagnosis. We evaluated febrile urinary tract infection incidence per 1 person, risk odds, expected values, and chi-square analysis. Results: This study examined 140 patients (79 males, 61 females). The patient's age at the first visit ranged from 2 days to 43.7 years old (median: 3.0 years old). The observation period was 0.6-43.7 years (median: 11.5 years). (i) Febrile urinary tract infection occurred in 68 cases, (ii) urinary management included: full clean intermittent catheterization: 49 cases, autoaugmented bladder: 15 cases, self-voiding: 8 cases, clean intermittent catheterization + indwelling catheter at night time: 5 cases, self-voiding + clean intermittent catheterization: 4 cases, vesicocutaneostomy: 2 cases, (iii) number of febrile urinary tract infection episodes: 2 times or less: 40 cases, 3-5 times: 20 cases, over 6 times: 8 cases, and (iv) total number of febrile urinary tract infection episodes was 183, with spring: 41, summer: 44, autumn: 37, and winter: 61. Risk odds of the incidence (one season vs. the other season) were spring: 0.870 (P = .425), summer: 0.954 (P = .784), autumn: 0.755 (P = .120), and winter 1.497 (P = .009). Conclusion: There is a significantly high incidence of febrile urinary tract infection in spina bifida patients in winter versus the other seasons. Cite this article as: Kitta T, Kanno-Kakibuchi Y, Chiba H, et al. Episodes of febrile urinary tract infections occur more often in the winter in patients with spina bifida. Urol Res Pract. 2023;49(3):211-215.
- 1 May 2023
- Published by AVES YAYINCILIK A.Ş. in Urology Research and Practice
- Vol. 49 (3) , 211-215
Open AccessEpisodes of Febrile Urinary Tract Infections Occur More Often in the Winter in Patients with Spina Bifida
Objective: Febrile urinary tract infections, which commonly occur in spina bifida patients, can cause renal dysfunction. To help prevent febrile urinary tract infection occurrence, a better understanding of any seasonal tendencies would be beneficial. Materials and Methods: Study points evaluated included: (i) with or without febrile urinary tract infections, (ii) type of urinary management in patients with febrile urinary tract infections, (iii) number of febrile urinary tract infection occurrences, and (iv) season associated with episode. Febrile urinary tract infection was defined by medical records specifically ascribing the term and clinical presentations consistent with the diagnosis. We evaluated febrile urinary tract infection incidence per 1 person, risk odds, expected values, and chi-square analysis. Results: This study examined 140 patients (79 males, 61 females). The patient's age at the first visit ranged from 2 days to 43.7 years old (median: 3.0 years old). The observation period was 0.6-43.7 years (median: 11.5 years). (i) Febrile urinary tract infection occurred in 68 cases, (ii) urinary management included: full clean intermittent catheterization: 49 cases, autoaugmented bladder: 15 cases, self-voiding: 8 cases, clean intermittent catheterization + indwelling catheter at night time: 5 cases, self-voiding + clean intermittent catheterization: 4 cases, vesicocutaneostomy: 2 cases, (iii) number of febrile urinary tract infection episodes: 2 times or less: 40 cases, 3-5 times: 20 cases, over 6 times: 8 cases, and (iv) total number of febrile urinary tract infection episodes was 183, with spring: 41, summer: 44, autumn: 37, and winter: 61. Risk odds of the incidence (one season vs. the other season) were spring: 0.870 (P = .425), summer: 0.954 (P = .784), autumn: 0.755 (P = .120), and winter 1.497 (P = .009). Conclusion: There is a significantly high incidence of febrile urinary tract infection in spina bifida patients in winter versus the other seasons. Cite this article as: Kitta T, Kanno-Kakibuchi Y, Chiba H, et al. Episodes of febrile urinary tract infections occur more often in the winter in patients with spina bifida. Urol Res Pract. 2023;49(3):211-215.
- Open Access
- 1 January 2023
- Published by AVES YAYINCILIK A.Ş. in Urology Research and Practice
- Vol. 49 (4) , 266-270
Detrusor-Overactivity-Related Voiding in Women Mimics Bladder Outflow Obstruction and Conceals Underactivity
Objective: Urodynamics of the storage phase showing detrusor overactivity is com- mon in neurogenic bladder patients. Terminal detrusor overactivity, which is defined by involuntary detrusor contraction that cannot be inhibited, causes urinary incon- tinence. Such incontinence causes a unique voiding in neurogenic bladder patients. During the voiding phase, the detrusor pressure at Qmax (Pdet.Qmax)/maximum flow rate (Qmax) (P/Q) is the gold standard for differentiating between detrusor underactiv- ity and bladder outflow obstruction. We investigated whether a valid identification of lower urinary tract dysfunction could be established from P/Q assessment of detrusor overactivity-related voiding patients. Methods: This study evaluated 2 types of voiding. Detrusor overactivity-related void- ing is involuntary detrusor contraction that results in micturition or voiding after per- mission to void when detrusor overactivity has occurred, while voluntary voiding is voiding voluntarily after permission to void and without terminal detrusor overactivity. We evaluated female patients with neurogenic bladder who could undergo micturition without catheterization. A pressure flow study compared the 2 groups. Results: Comparison of the detrusor overactivity-related voiding group (n=20) and the voluntary voiding group (n=12) found statistically significant differences with a lower Qmax and higher Pdet.Qmax (P=.01) in the detrusor overactivity-related void- ing group. The linear regression analysis P/Q plot showed the positivity and negativity value of the slope that was reversed in the 2 groups (−0.089 vs. 0.198). Conclusion: Current results showed different P/Q plot patterns between 2 types of voiding in patients with neurogenic bladder. These findings suggest there is increased detrusor pressure observed in detrusor overactivity-related voiding that mimics out- flow obstruction. Cite this article as: Kitta T, Kobayashi S, Togo M, et al. Detrusor-overactivity-related voiding in women mimics bladder outflow obstruction and conceals underactivity. Urol Res Pract. 2023;49(4):266-270.
- 1 January 2023
- Published by AVES YAYINCILIK A.Ş. in Urology Research and Practice
- Vol. 49 (4) , 266-270
Open AccessDetrusor-Overactivity-Related Voiding in Women Mimics Bladder Outflow Obstruction and Conceals Underactivity
Objective: Urodynamics of the storage phase showing detrusor overactivity is com- mon in neurogenic bladder patients. Terminal detrusor overactivity, which is defined by involuntary detrusor contraction that cannot be inhibited, causes urinary incon- tinence. Such incontinence causes a unique voiding in neurogenic bladder patients. During the voiding phase, the detrusor pressure at Qmax (Pdet.Qmax)/maximum flow rate (Qmax) (P/Q) is the gold standard for differentiating between detrusor underactiv- ity and bladder outflow obstruction. We investigated whether a valid identification of lower urinary tract dysfunction could be established from P/Q assessment of detrusor overactivity-related voiding patients. Methods: This study evaluated 2 types of voiding. Detrusor overactivity-related void- ing is involuntary detrusor contraction that results in micturition or voiding after per- mission to void when detrusor overactivity has occurred, while voluntary voiding is voiding voluntarily after permission to void and without terminal detrusor overactivity. We evaluated female patients with neurogenic bladder who could undergo micturition without catheterization. A pressure flow study compared the 2 groups. Results: Comparison of the detrusor overactivity-related voiding group (n=20) and the voluntary voiding group (n=12) found statistically significant differences with a lower Qmax and higher Pdet.Qmax (P=.01) in the detrusor overactivity-related void- ing group. The linear regression analysis P/Q plot showed the positivity and negativity value of the slope that was reversed in the 2 groups (−0.089 vs. 0.198). Conclusion: Current results showed different P/Q plot patterns between 2 types of voiding in patients with neurogenic bladder. These findings suggest there is increased detrusor pressure observed in detrusor overactivity-related voiding that mimics out- flow obstruction. Cite this article as: Kitta T, Kobayashi S, Togo M, et al. Detrusor-overactivity-related voiding in women mimics bladder outflow obstruction and conceals underactivity. Urol Res Pract. 2023;49(4):266-270.
- Open Access
- 27 April 2020
- Published by Wiley in Neurourology and Urodynamics
- Vol. 39 (5) , 1464-1471
Reliability of manometry for assessing pelvic floor muscle function in healthy men
Objectives: To the best of our knowledge, no study has examined the reliability of assessment methods for male pelvic floor muscle (PFM) function. Therefore, this study aimed to clarify the reliability of manometry with an anal sensor (Peritron cat 9300A) to assess PFM function in healthy men.Methods: Healthy male subjects (n = 21) without urinary leakage underwent testing to assess PFM function, and intra‐ and interrater reliability tests among examiners were performed. The PFM function included maximal anorectal squeeze pressure, endurance, mean anorectal squeeze pressure, gradient, and area under the curve during PFM voluntary contraction.Results: Participants had a median age of 38 years (range 26‐51), and a mean BMI of 23.2 ± 2.0 kg/m2. Satisfactory intra‐ and interrater reliability scores were found for resting pressure, anorectal squeeze pressure, and endurance. The intra‐rater reliability of resting pressure, anorectal squeeze pressure, and endurance were 0.71, 0.89, and 0.75 for examiner 1 and 0.72, 0.89, and 0.87 for examiner 2. The interrater reliability for resting pressure, anorectal squeeze pressure, and endurance were 0.58, 0.93, and 0.61, respectively.Conclusions: This is the first prospective study showing the favorable intra‐ and interrater reliability of manometry for PFM function in healthy men. Our findings demonstrated that manometry can provide both reliable and reproducible data regarding PFM function in continent men, suggesting Peritron cat 9300A can be used to evaluate the PFM function in men.
- 27 April 2020
- Published by Wiley in Neurourology and Urodynamics
- Vol. 39 (5) , 1464-1471
Open AccessReliability of manometry for assessing pelvic floor muscle function in healthy men
Objectives: To the best of our knowledge, no study has examined the reliability of assessment methods for male pelvic floor muscle (PFM) function. Therefore, this study aimed to clarify the reliability of manometry with an anal sensor (Peritron cat 9300A) to assess PFM function in healthy men.Methods: Healthy male subjects (n = 21) without urinary leakage underwent testing to assess PFM function, and intra‐ and interrater reliability tests among examiners were performed. The PFM function included maximal anorectal squeeze pressure, endurance, mean anorectal squeeze pressure, gradient, and area under the curve during PFM voluntary contraction.Results: Participants had a median age of 38 years (range 26‐51), and a mean BMI of 23.2 ± 2.0 kg/m2. Satisfactory intra‐ and interrater reliability scores were found for resting pressure, anorectal squeeze pressure, and endurance. The intra‐rater reliability of resting pressure, anorectal squeeze pressure, and endurance were 0.71, 0.89, and 0.75 for examiner 1 and 0.72, 0.89, and 0.87 for examiner 2. The interrater reliability for resting pressure, anorectal squeeze pressure, and endurance were 0.58, 0.93, and 0.61, respectively.Conclusions: This is the first prospective study showing the favorable intra‐ and interrater reliability of manometry for PFM function in healthy men. Our findings demonstrated that manometry can provide both reliable and reproducible data regarding PFM function in continent men, suggesting Peritron cat 9300A can be used to evaluate the PFM function in men.
- 1 January 2005
- Published by Springer Nature in International Journal of Hematology
- Vol. 81 (1) , 18-25
Expansion of CD34 + Cells on Telomerized Human Stromal Cells without Losing Erythroid-Differentiation Potential in a Serum-Free Condition
Erythropoiesis progresses from stem cell expansion on stromal cells through the formation of an erythroblastic island. Our aim was to assess the feasibility of using human stromal cells for erythroid...
- 1 January 2005
- Published by Springer Nature in International Journal of Hematology
- Vol. 81 (1) , 18-25
Expansion of CD34 + Cells on Telomerized Human Stromal Cells without Losing Erythroid-Differentiation Potential in a Serum-Free Condition
Erythropoiesis progresses from stem cell expansion on stromal cells through the formation of an erythroblastic island. Our aim was to assess the feasibility of using human stromal cells for erythroid...